LCM
CALA

Laurion Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Laurion Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,805
Closed -$375K – 1358
2019
Q2 		$375K Buy
+4,805
New +$545K ﹤0.01% 741
2017
Q2 		– Sell
-2,180
Closed -$504K – 1955
2017
Q1 		$504K Buy
+2,180
New +$377K ﹤0.01% 912

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Laurion Capital Management's CALA Position: Q3 2019 in Review

Laurion Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2019, closing a stake of 4,805 shares — an estimated $375K sold.

Laurion Capital Management first reported a position in CALA in Q1 2017 and held it in 2 quarters. The position peaked at $504K in Q1 2017. 85 funds tracked by Wall St. Rank hold CALA as of Q3 2019.

  • Laurion Capital Management reported no remaining Calithera Biosciences, Inc position as of Q3 2019 after selling out during the quarter.
  • Laurion Capital Management sold 4,805 Calithera Biosciences, Inc shares in Q3 2019, an estimated $375K.
  • Laurion Capital Management first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 2 quarters.
  • Laurion Capital Management's Calithera Biosciences, Inc position peaked at $504K in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2019.

Based on Laurion Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.